2008
DOI: 10.1097/ta.0b013e318058245e
|View full text |Cite
|
Sign up to set email alerts
|

The Effects of Decreasing Low-Molecular Weight Hemoglobin Components of Hemoglobin-Based Oxygen Carriers in Swine With Hemorrhagic Shock

Abstract: Although purification from 31% to 2% low-MW Hb content significantly decreased vasoactive responses, further purification to 0.4% had no additional clinically measurable effects in severe HS. If further diminution in HBOC vasoactivity is desired for use in HS, additional technical approaches may be required.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
19
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
5
2
1

Relationship

1
7

Authors

Journals

citations
Cited by 32 publications
(21 citation statements)
references
References 38 publications
2
19
0
Order By: Relevance
“…We confirmed that reduction of tetrameric/dimeric haemoglobin from 32% to <3% reduced HBOC-induced systemic and pulmonary hypertension and vascular resistance but further reduction to 0.4% had no additive effect. 25 Then, based on NO scavenging as the basis for HBOC vasoconstriction, we hypothesized that pharmacologic replenishment of blood NO could attenuate HBOCinduced hypertension and vascular resistance elevation. Clinically used vasodilators, NaNO 2 (for cyanide toxicity), SNP (for malignant hypertension), and NTG (for acute coronary syndromes) were investigated.…”
Section: Discussionmentioning
confidence: 99%
“…We confirmed that reduction of tetrameric/dimeric haemoglobin from 32% to <3% reduced HBOC-induced systemic and pulmonary hypertension and vascular resistance but further reduction to 0.4% had no additive effect. 25 Then, based on NO scavenging as the basis for HBOC vasoconstriction, we hypothesized that pharmacologic replenishment of blood NO could attenuate HBOCinduced hypertension and vascular resistance elevation. Clinically used vasodilators, NaNO 2 (for cyanide toxicity), SNP (for malignant hypertension), and NTG (for acute coronary syndromes) were investigated.…”
Section: Discussionmentioning
confidence: 99%
“…KCN (potassium cyanide), KFe(CN) 6 (potassium ferricyanide), and all other chemicals were purchased from Fisher Scientific (Pittsburgh, PA). HF cartridges were obtained from Spectrum Labs (Rancho Dominguez, CA).…”
Section: Methodsmentioning
confidence: 99%
“…[1][2][3][4] Although the exact mechanism of vasoconstriction upon HBOC transfusion is not known, there are two major hypotheses in the literature, namely, nitric oxide (NO) scavenging (by far the most popular one of the two) and oxygen oversupply. [5][6][7] To limit/prevent vasoconstriction by either mechanism, the size (i.e., molecular weight, MW) of the HBOC should be increased and free hemoglobin (Hb) and low-MW components should be removed from solution to reduce the interaction of the HBOC with the endothelium. 6,8,9 Therefore, strategies targeted toward increasing the size of HBOCs should be able to reduce these unwanted side effects.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Their affinity for oxygen is lower than that of PRBC. Larger, heavier, highly polymerized HBOCs are less vasoactive than smaller molecules [47,48].…”
Section: Blood Substitutesmentioning
confidence: 99%